妇科肿瘤手术后入住重症监护病房:基于系统评价的结果与作者建议
该系统评价纳入7项研究共3820例妇科恶性肿瘤手术患者,其中1680例术后入住CCU。分析显示,高龄、较高Charlson共病指数(CCI)评分、较长手术时间、大量失血和肠切除与CCU入住概率更高相关;患者年龄、手术时间、失血量和肠切除是CCU延长停留的显著预测因素。作者结论认为,妇科恶性肿瘤术后CCU入住和停留时间由特定患者特征及术中指标驱动,需进一步研究验证哪些高危患者能从术后CCU监护中获益,以确保良好术后结局和成本效益。
要点
- 纳入7项研究共3820例妇科恶性肿瘤手术患者,其中1680例术后入住CCU。
- 高龄、较高CCI评分、较长手术时间、大量失血和肠切除与CCU入住概率更高相关。
- 患者年龄、手术时间、失血量和肠切除是CCU延长停留的显著预测因素。
- 作者结论:CCU入住和停留时间由特定患者特征及术中指标驱动。
- 作者指出需进一步研究验证哪些高危患者能从术后CCU监护中获益。
适用人群与场景
- 接受妇科恶性肿瘤手术并需要术后入住CCU的女性患者(系统评价纳入标准)。
研究设计与关键结果
- 系统评价纳入7项研究,共3820例妇科恶性肿瘤手术患者,其中1680例术后入住CCU。
- 高龄、较高Charlson共病指数(CCI)评分、较长手术时间、大量失血和肠切除与CCU入住概率更高相关。
- 患者年龄、手术时间、失血量和肠切除是CCU延长停留的显著预测因素。
证据类型、等级与局限
- 证据类型:系统评价。
- 作者结论:妇科恶性肿瘤术后CCU入住和停留时间由特定患者特征及术中指标驱动。
- 局限:作者指出需进一步研究验证哪些高危患者能从术后CCU监护中获益,以确保良好术后结局和成本效益。
对床旁实践的改变
- 作者认为,妇科恶性肿瘤术后CCU入住和停留时间由特定患者特征(高龄、较高CCI评分)及术中指标(较长手术时间、大量失血、肠切除)驱动。
- 作者指出需进一步研究验证哪些高危患者能从术后CCU监护中获益,以确保良好术后结局和成本效益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND/AIM: The present study aimed to evaluate the predictors of admission to the Critical Care Units (CCUs) and factors predisposing to prolonged stay in CCUs after gynecological oncology surgery.
PATIENTS AND METHODS: Studies which addressed cases of women who underwent surgery for gynecological malignancies and required postoperative CCU admission were included.
RESULTS: Seven studies with 3820 patients were included. Among them, 1680 required admission to CCU. Advanced age, higher Charlson Comorbidity Index (CCI) score, longer operative times, protracted blood loss and intestinal resection were associated with higher probability of CCU admission. Patients' age, operative times, blood loos and intestinal resection were significant predictors of prolonged stay to CCUs.
CONCLUSION: Admission to CCU and length of stay following surgery for gynecologic malignancies is driven by specific patient characteristics as well as intraoperative values. Further studies are needed to validate high risk patients who will benefit from postoperative care to CCUs to ensure favorable postoperative outcomes and cost-effectiveness.
参考来源
- Thomakos N, Prodromidou A, Haidopoulos D, et al. Postoperative Admission in Critical Care Units Following Gynecologic Oncology Surgery: Outcomes Based on a Systematic Review and Authors' Recommendations. In Vivo. 2020. PMID: 32871742. doi:10.21873/invivo.12030
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。